bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Mar 6, 2026, 4:00 PM EST
1.012
-0.028 (-2.72%)
After-hours: Mar 6, 2026, 7:12 PM EST

bioAffinity Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6.789.362.530--
Revenue Growth (YoY)
-27.66%269.68%52627.44%---
Cost of Revenue
4.895.981.740--
Gross Profit
1.893.380.790--
Selling, General & Admin
9.89.946.792.481.070.99
Depreciation & Amortization Expenses
0.530.610.250.01--
Research & Development
1.941.781.721.521.141.61
Total Operating Expenses
12.2712.338.764.022.212.6
Operating Income
-10.38-8.95-7.97-4.01-2.21-2.6
Interest Income
0.010.020.120.0500
Interest Expense
-0.06-0.09-0.04-2.53-1-0.38
Other Non-Operating Income (Expense)
-8.560-0.03-1.65-3.12-4.28
Total Non-Operating Income (Expense)
-8.61-0.070.06-4.14-4.12-4.66
Pretax Income
-14.7-9.03-7.92-8.15-6.32-7.27
Provision for Income Taxes
0-0.01-0.02-0-0-0
Net Income
-14.74-9.04-7.94-8.15-6.33-7.27
Net Income to Common
-14.74-9.04-7.94-8.15-6.33-7.27
Shares Outstanding (Basic)
100000
Shares Outstanding (Diluted)
100000
Shares Change (YoY)
102.35%38.61%94.43%67.83%0.31%-
EPS (Basic)
-20.92-22.50-27.30-54.30-70.80-81.60
EPS (Diluted)
-20.92-22.50-27.30-54.30-70.80-81.60
Free Cash Flow
-8.51-7.34-6.06-4.29-2.05-2.21
Free Cash Flow Per Share
-11.72-18.17-20.79-28.61--
Gross Margin
27.86%36.09%31.26%90.28%--
Operating Margin
-153.20%-95.64%-314.84%-83511.51%--
Profit Margin
-217.50%-96.56%-313.41%-169771.25%--
FCF Margin
-125.53%-78.44%-239.32%-89336.50%--
EBITDA
-9.85-8.35-7.72-4-2.2-2.58
EBITDA Margin
-145.31%-89.17%-304.98%-83299.52%--
EBIT
-10.38-8.95-7.97-4.01-2.21-2.6
EBIT Margin
-153.20%-95.64%-314.84%-83511.51%--
Effective Tax Rate
-0.00%0.13%0.27%0.03%0.03%0.04%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q